FARALLON CAPITAL MANAGEMENT, L.L.C.FARALLON CAPITAL MANAGEMENT, L.L.C.

Institutional investor · Portfolio as of Q4 2020

SEC EDGAR SourceSEC Filings

Top Holdings136 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

IQVIA HOLDINGS INC

4M$724.5M4.4%$125.48+41.47%
9 qtrssince 2018-Q4
Increased
66

ALPHABET INC-CL C

361,094$632.6M3.8%$62.91+37.22%
9 qtrssince 2018-Q4
Decreased
0

T-MOBILE US INC

3.9M$532.5M3.2%$104.79+22.88%
3 qtrssince 2020-Q2
Increased
63

THERMO FISHER SCIENTIFIC INC

1.1M$519M3.1%$313.02+45.58%
5 qtrssince 2019-Q4
Increased
58
SPYSPY
PUT

STATE STREET SPDR S&P 500 ETF TRUST CL USD INC

1.4M$510.3M3.1%
New

VISA INC-CLASS A SHARES

2.2M$487.4M2.9%$155.31+35.01%
9 qtrssince 2018-Q4
Increased
68

AON PLC

2.3M$479.9M2.9%$188.69+7.59%
3 qtrssince 2020-Q2
Increased
67

BOSTON SCIENTIFIC CORP

13.2M$475.9M2.9%$36.93-3.74%
2 qtrssince 2020-Q3
Increased
77

FIDELITY NATIONAL INFO SERV

3.1M$445.5M2.7%$102.06+22.35%
9 qtrssince 2018-Q4
Decreased
0

ARAMARK

11M$424.2M2.6%$25.860.00%
1 qtr
New
81

CENTENE CORP

6.9M$411.2M2.5%$57.70+2.12%
4 qtrssince 2020-Q1
Decreased
0

ANTHEM INC

1.3M$409.4M2.5%$246.70+18.95%
9 qtrssince 2018-Q4
Unchanged
0

MICROSOFT CORP

1.8M$391.1M2.4%$128.72+65.25%
9 qtrssince 2018-Q4
Increased
61

WABTEC CORP

5M$365.8M2.2%$62.25+13.05%
9 qtrssince 2018-Q4
Decreased
0
XLNXXLNXDelisted

XILINX INC

2.6M$362.4M2.2%
1 qtr
New
80

CHARTER COMMUNICATIONS INC - CLASS A

546,931$361.8M2.2%$304.08+114.91%
9 qtrssince 2018-Q4
Decreased
0
ALXNALXNDelisted

ALEXION PHARMACEUTICALS INC

2.2M$351.1M2.1%
1 qtr
New
80

NEW YORK TIMES CO-A

6.5M$338.9M2.0%$39.90+22.82%
3 qtrssince 2020-Q2
Decreased
0
XLRNXLRNDelisted

ACCELERON PHARMA INC

2.6M$332.6M2.0%
9 qtrssince 2018-Q4
Unchanged
0

RAYTHEON TECHNOLOGIES CORP

4.5M$324.8M2.0%$63.080.00%
1 qtr
New
71
$16.6B
AUM
136
Positions
Q4 2020
Filing
Rating · 1.0
Quarterly Portfolio Change
-14%Q3'19$13.2B+12%Q4'19$14.8B-21%Q1'20$11.7B+7%Q2'20$12.5B+16%Q3'20$14.5B+15%Q4'20$16.6B
Activity profile
$ moved · Q4'20
New38%Increased18%Decreased16%Exited28%
Composition
Equity vs derivatives
Equity97%Puts3%Calls0%
Holding period
Avg 3.7 quarters
<1Q26%1-4Q29%1-2Y16%2Y+29%

FARALLON CAPITAL MANAGEMENT, L.L.C. manages $16.6B across 136 positions as of Q4 2020. Top holdings: IQV (4.4%), GOOG (3.8%), TMUS (3.2%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 1/5.0.

Q4 2020 Summary

Active quarter - 42 new positions, 28 exits, 30 increased. Top move: ARMK (NEW, conviction 81). Portfolio: $16.6B across 136 positions.

Top holdings by portfolio weight

Total AUM$16B
IQV4.36%
GOOG3.80%
TMUS3.20%
TMO3.12%
V2.93%
AON2.89%
BSX2.86%
FIS2.68%
ARMK2.55%
CNC2.47%
Other2.46%

Portfolio allocation by GICS sector

Sectors10
Healthcare31.36%
Unknown20.34%
Communication Services14.18%
Financial Services10.86%
Technology9.25%
Industrials8.83%
Consumer Cyclical2.48%
Basic Materials1.86%
Utilities0.59%
Real Estate0.25%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Healthcare, Unknown, Communication Services
Compare DNA across all funds
7-dimension quality assessment
Weak(1.0 / 5.0)
Track RecordNo data
Conviction43
Concentration66
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
CRNXCRNXCRINETICS PHARMACEUTICALS IN
Q3 2024 Q2 2026+8.5M shares+$314.1M
7Q
BBIOBBIOBRIDGEBIO PHARMA INC
Q4 2024 Q2 2026+9M shares+$755.7M
5Q
BSXBSXBOSTON SCIENTIFIC CORP
Q2 2025 Q2 2026+6.8M shares+$69.5M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used